RK

Ranjeet Kumar Panday

Active Director Director DIN 08300124
DIN 08300124 First appointment Dec 2018 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Dec 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Ranjeet Kumar Panday

Data last updated:

Ranjeet Kumar Panday is a Director at Galchem Pharmaceuticals Private Limited (since 2020) and Director at Reeveet Pharma Private Limited (since 2018). The companies operate in Chemicals and Trading.

DIN 08300124
Primary Designation Director
Industry Chemicals
First Appointment 11 Dec 2018
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jan 20202020Active
Reeveet Pharma Private Limited U51909BR2018PTC040212
Director11 Dec 20182018Under Process Of Striking Off

Board colleagues of Ranjeet Kumar Panday

Directorship timeline

Open interactive timeline →
Galchem Pharmaceuticals Private Limited
Reeveet Pharma Private Limited
Premium access

Shareholding and investment profile for Ranjeet Kumar Panday

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjeet Kumar Panday

Ranjeet Kumar Panday currently holds 2 directorships: Galchem Pharmaceuticals Private Limited (Director, since 07 Jan 2020); Reeveet Pharma Private Limited (Director, since 11 Dec 2018).

Ranjeet Kumar Panday was first appointed on 11 Dec 2018 as Director at Reeveet Pharma Private Limited. The most recent appointment on record is 07 Jan 2020 at Galchem Pharmaceuticals Private Limited.

The current boards of Ranjeet Kumar Panday's companies include Sanjay Kumar Pandey (Galchem Pharmaceuticals Private Limited), Rajeev Ranjan (Reeveet Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available